JN

Jaykant Naginbhai Shah

Director Additional Director DIN 03043191
DIN 03043191 First appointment Jan 2003 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaykant Naginbhai Shah

Data last updated:

Jaykant Naginbhai Shah was an Additional Director at Kentreck Laboratories Pvt Ltd (2017) and Director at Gmbell Healthcare (India) Private Limited (2003–2020). The companies operate in Pharma.

DIN 03043191
Primary Designation Additional Director
Industry Pharma
First Appointment 16 Jan 2003

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kentreck Laboratories Pvt Ltd U24231GJ1989PTC012216
Additional Director28 Mar 20171989₹17.30 Cr (FY 2025)Active
Director16 Jan 20032003₹2.70 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kentreck Laboratories Pvt Ltd
Gmbell Healthcare (India) Private Limited
Premium access

Shareholding and investment profile for Jaykant Naginbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaykant Naginbhai Shah

Jaykant Naginbhai Shah was first appointed on 16 Jan 2003 as Director at Gmbell Healthcare (India) Private Limited. The most recent appointment on record is 28 Mar 2017 at Kentreck Laboratories Pvt Ltd.

Jaykant Naginbhai Shah held 2 earlier board appointments: Kentreck Laboratories Pvt Ltd (Additional Director, 28 Mar 2017 to 25 Jul 2017); Gmbell Healthcare (India) Private Limited (Director, 16 Jan 2003 to 31 Jul 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available